Skip to main content

GOLDMAN SACHS GROUP INC

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in ACRS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,207,590
+$303,760 QoQ
Shares Held
588,691
-6.9% QoQ
Ownership
0.422%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 97.558481444425.ToString("F0")% Shared 2.413490269088537.ToString("F0")% None 0.028028286486458942.ToString("F0")%

Common Shares in ACRS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. ACRS ranks #211 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACRS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,207,590 588,691
2025-12-31 $1,903,830 632,502
2025-09-30 $1,816,495 956,051
2025-06-30 $222,331 156,572
2025-03-31 $850,607 555,953
2024-12-31 $1,062,895 428,587
2024-09-30 $346,789 301,556
2024-06-30 $1,008,281 916,620
2024-03-31 $180,806 145,812
2023-12-31 $546,923 520,880
2023-09-30 $1,868,822 272,821
2023-06-30 $4,042,080 389,786
2023-03-31 $2,399,832 296,642
2022-12-31 $5,469,942 347,298
2022-09-30 $6,646,166 422,247
2022-06-30 $5,694,129 407,889
2022-03-31 $4,455,832 258,459
2021-12-31 $3,216,130 221,192
2021-09-30 $7,939,692 441,094
2021-06-30 $5,711,828 325,275
2021-03-31 $3,038,665 120,582
2020-12-31 $170,206 26,307
2020-09-30 $67,608 26,307
2020-06-30 $56,881 35,112
2020-03-31 $25,049 24,086